HUT65627A - Process for producing of alkynyl-derivatives of indolyl-methoxybenzoyl-benzenesulphonemide compounds and pharmaceutical compositions comprising them - Google Patents

Process for producing of alkynyl-derivatives of indolyl-methoxybenzoyl-benzenesulphonemide compounds and pharmaceutical compositions comprising them Download PDF

Info

Publication number
HUT65627A
HUT65627A HU9203343A HU9203343A HUT65627A HU T65627 A HUT65627 A HU T65627A HU 9203343 A HU9203343 A HU 9203343A HU 9203343 A HU9203343 A HU 9203343A HU T65627 A HUT65627 A HU T65627A
Authority
HU
Hungary
Prior art keywords
formula
group
compound
benzenesulfonamide
ylmethyl
Prior art date
Application number
HU9203343A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9203343D0 (en
Inventor
Rolf Schurter
Alfred Sallmann
Marc Gerspacher
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of HU9203343D0 publication Critical patent/HU9203343D0/hu
Publication of HUT65627A publication Critical patent/HUT65627A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
HU9203343A 1991-10-25 1992-10-22 Process for producing of alkynyl-derivatives of indolyl-methoxybenzoyl-benzenesulphonemide compounds and pharmaceutical compositions comprising them HUT65627A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH313591 1991-10-25

Publications (2)

Publication Number Publication Date
HU9203343D0 HU9203343D0 (en) 1992-12-28
HUT65627A true HUT65627A (en) 1994-07-28

Family

ID=4249377

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9203343A HUT65627A (en) 1991-10-25 1992-10-22 Process for producing of alkynyl-derivatives of indolyl-methoxybenzoyl-benzenesulphonemide compounds and pharmaceutical compositions comprising them

Country Status (13)

Country Link
US (1) US5248693A (cg-RX-API-DMAC7.html)
EP (1) EP0539329A1 (cg-RX-API-DMAC7.html)
JP (1) JPH05221980A (cg-RX-API-DMAC7.html)
KR (1) KR930007902A (cg-RX-API-DMAC7.html)
AU (1) AU2723292A (cg-RX-API-DMAC7.html)
CA (1) CA2081262A1 (cg-RX-API-DMAC7.html)
FI (1) FI924768A7 (cg-RX-API-DMAC7.html)
HU (1) HUT65627A (cg-RX-API-DMAC7.html)
IL (1) IL103524A0 (cg-RX-API-DMAC7.html)
MX (1) MX9206127A (cg-RX-API-DMAC7.html)
NO (1) NO924112L (cg-RX-API-DMAC7.html)
TW (1) TW207531B (cg-RX-API-DMAC7.html)
ZA (1) ZA928201B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0539330B1 (de) * 1991-10-25 1995-05-17 Ciba-Geigy Ag Verfahren zur Herstellung substituierter Indole
US5439929A (en) * 1994-03-01 1995-08-08 Pfizer Inc. Bicyclic carbamates, pharmaceutical compositions and use
GB9804648D0 (en) 1998-03-06 1998-04-29 Zeneca Ltd Chemical compounds
GB9805520D0 (en) * 1998-03-17 1998-05-13 Zeneca Ltd Chemical compounds
GB9811427D0 (en) 1998-05-29 1998-07-22 Zeneca Ltd Chemical compounds
JP2003508514A (ja) 1999-09-04 2003-03-04 アストラゼネカ アクチボラグ 化学的化合物
ES2307528T3 (es) 1999-09-04 2008-12-01 Astrazeneca Ab Amidas como inhibidores para la piruvato deshidrogenasa.
HUP0202725A3 (en) 1999-09-04 2005-04-28 Astrazeneca Ab Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity, process for their preparation and pharmaceutical compositions containing them
GB0120471D0 (en) * 2001-08-23 2001-10-17 Astrazeneca Ab Chemical compounds
WO2014165741A2 (en) * 2013-04-05 2014-10-09 Miller Leonard B Methods and articles of manufacture for the treatment of skin
CN108084077B (zh) * 2017-12-20 2020-04-14 江汉大学 一种扎鲁司特中间体的合成方法
CN108785251B (zh) * 2018-01-23 2020-11-24 盛元医药广州有限公司 一种眼用药物组合物及其制备方法和应用
CN115458713B (zh) * 2022-10-21 2024-04-19 深圳市山木新能源科技股份有限公司 一种聚阴离子钠离子电池电极

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives
GB8623429D0 (en) * 1985-10-17 1986-11-05 Ici America Inc Carboximide derivatives
DK496086A (da) * 1985-10-17 1987-04-18 Ici America Inc Heterocykliske forbindelser
GB8906032D0 (en) * 1988-04-14 1989-04-26 Ici America Inc Hetera-aliphatic carboxamides
ES2063479T3 (es) * 1990-05-04 1995-01-01 Ciba Geigy Ag Indoles substituidos.

Also Published As

Publication number Publication date
NO924112L (no) 1993-04-26
EP0539329A1 (de) 1993-04-28
HU9203343D0 (en) 1992-12-28
FI924768A0 (fi) 1992-10-21
TW207531B (cg-RX-API-DMAC7.html) 1993-06-11
MX9206127A (es) 1993-08-01
FI924768L (fi) 1993-04-26
JPH05221980A (ja) 1993-08-31
KR930007902A (ko) 1993-05-20
NO924112D0 (no) 1992-10-23
US5248693A (en) 1993-09-28
ZA928201B (en) 1993-04-28
AU2723292A (en) 1993-04-29
CA2081262A1 (en) 1993-04-26
IL103524A0 (en) 1993-03-15
FI924768A7 (fi) 1993-04-26

Similar Documents

Publication Publication Date Title
DE60320439T2 (de) INDOLDERIVATE ALS ß2-AGONISTEN
EP1212317B1 (en) Indole derivatives and their use for the treatment of osteoporosis amongst other applications
HUT65627A (en) Process for producing of alkynyl-derivatives of indolyl-methoxybenzoyl-benzenesulphonemide compounds and pharmaceutical compositions comprising them
JPH10505336A (ja) インデンｓＰＬＡ▲下２▼インヒビター
JPH066576B2 (ja) アミノキノリン誘導体及びその製法
DE60302156T2 (de) Indolderivate und deren verwendung als liganden der receptoren cb2
AU749319B2 (en) Indole derivatives useful A.O. for the treatment of osteoporosis
US6506758B2 (en) Indole derivatives useful A.O. for the treatment of osteoporosis
JP2511204B2 (ja) 置換インド―ル
JPS60120867A (ja) 新規カルボスチリル誘導体
US4035368A (en) Substituted 3-(1H-tetrazol-5-yl)-quinoline compounds
AU683481B2 (en) Quinoline compounds
RU2115648C1 (ru) Производные тетразола и антиаллергическая композиция
JP2003509491A (ja) 新規なｓＰＬＡ２インヒビター
KR970011454B1 (ko) 신규의 아미드 화합물
JPH0425268B2 (cg-RX-API-DMAC7.html)
JPH0641051A (ja) フェノキシ酢酸誘導体
JPH05279336A (ja) フェノキシ酢酸誘導体
JPS58146568A (ja) 新規なジベンズアゼピン−２−酢酸誘導体
HK1032953B (en) Indole derivatives useful a.o. for the treatment of osteoporosis
JP2000503646A (ja) グアニジン誘導体
JPH07501532A (ja) 抗喘息性，および気管支抗炎症作用を有する［３Ｈ，７Ｈ］チアゾール［３，４‐ａ］ピリジン

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee